The Value of Critical Care Ultrasound in Rapid Screening, Diagnosis, Evaluation of Effectiveness and Intensive Prevention of Novel Coronavirus Pneumonia (COVID-19)

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000030185

Enrollment

Unknown

Registered

2020-02-24

Start date

2020-02-24

Completion date

Unknown

Last updated

2020-02-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

novel coronavirus pneumonia (COVID-19)

Interventions

Gold Standard:Clinical outcome and Viral nucleic acid detection

Index test:critical&#32

care&#32

ultrasound&#32

examination

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who meet the diagnostic criteria of pneumonia caused by novel coronavirus.

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
28day mortality;	—

Secondary

Measure	Time frame
length of stay;length of ICU;Rate of ICU admission;organ function;rate of intubated;length of mechanical ventilation;	—

Countries

China

Contacts

Public ContactWanhong Yin

Department of Critical Care Medicine, West China Hospital of Sichuan University

doctorwhy@126.com+86 13518106758

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026